BIAF (bioAffinity Technologies) Inventory Turnover: 14.08 (As of Mar. 2026)

What is bioAffinity Technologies Inventory Turnover?

bioAffinity Technologies BIAF -1.48% 44 Inventory Turnover is 14.08 as of Mar. 2026. GuruFocus rates BIAF with a GF Score™ of 44/100 and a GF Value™ of $4.27 (Possible Value Trap). The stock has 3 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. bioAffinity Technologies's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.93 Mil. bioAffinity Technologies's Average Total Inventories for the quarter that ended in Mar. 2026 was $0.07 Mil. bioAffinity Technologies's Inventory Turnover for the quarter that ended in Mar. 2026 was 14.08.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. bioAffinity Technologies's Days Inventory for the three months ended in Mar. 2026 was 6.48.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. bioAffinity Technologies's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.05.

bioAffinity Technologies (NAS:BIAF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

bioAffinity Technologies's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	0.066	/	0.929	*	365 / 4
	=	6.48

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

bioAffinity Technologies's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	0.066	/	1.352
	=	0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

bioAffinity Technologies Inventory Turnover Related Terms

bioAffinity Technologies Inventory Turnover Historical Data

* Premium members only.

The historical data trend for bioAffinity Technologies's Inventory Turnover can be seen below:

bioAffinity Technologies Inventory Turnover Chart

bioAffinity Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

0.00

0.17

145.00

260.13

103.10

bioAffinity Technologies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															40.84	24.48	23.85	20.22	14.08

44GF Score

bioAffinity Technologies Inc BIAF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

bioAffinity Technologies Inventory Turnover Calculation

bioAffinity Technologies's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	4.227	/ (	(0.028	+	0.054)	/	2 )
=	4.227	/	0.041
=	103.10

bioAffinity Technologies's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	0.929	/ (	(0.054	+	0.078)	/	2 )
=	0.929	/	0.066
=	14.08

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 14.08 mean?

bioAffinity Technologies (BIAF) has a Inventory Turnover of 14.08 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on bioAffinity Technologies and its competitors.

Is bioAffinity Technologies' Inventory Turnover too high?

bioAffinity Technologies' current Inventory Turnover is 14.08. Overall, bioAffinity Technologies has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does bioAffinity Technologies' Inventory Turnover compare to NDRA and ISPC?

bioAffinity Technologies' Inventory Turnover of 14.08 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Medical Diagnostics & Research company?

A good Inventory Turnover depends on the Medical Diagnostics & Research industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on bioAffinity Technologies and its competitors. bioAffinity Technologies's current Inventory Turnover is 14.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is bioAffinity Technologies stock overvalued right now?

Based on GuruFocus' analysis, bioAffinity Technologies (BIAF) is currently considered Possible Value Trap. The stock's GF Value™ is $4.27, compared to a current price of $0.76 — trading 82.2% below its estimated fair value. The current Inventory Turnover is 14.08. bioAffinity Technologies' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For bioAffinity Technologies (BIAF), the current Inventory Turnover is 14.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is bioAffinity Technologies (BIAF) Overvalued in 2026?

Based on GuruFocus' analysis, bioAffinity Technologies stock appears to be undervalued. The current stock price of $0.76 is trading 82.2% below its estimated GF Value™ of $4.27. GuruFocus considers bioAffinity Technologies to be Possible Value Trap.

Key valuation signals for BIAF:

Inventory Turnover: 14.08
GF Value™: $4.27 vs. price of $0.76 (82.2% below fair value)
GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the BIAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

bioAffinity Technologies Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies NDRA ISPC ADVB MBAI FUNI IVRO PRPH XWEL IDTA NSTM TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN

Address 3300 Nacogdoches Road, Suite 216, San Antonio, TX, USA, 78217

Website https://www.bioaffinitytech.com

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

44GF Score

Get the complete analysis for BIAF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.76

Price

$4.27

GF Value

View BIAF Analysis

See Inventory Turnover data for all stocks →